Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Italy Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20043
20057
20065
20077
20082
20093
20104
20112
20124
20138
20147
20153
20165
20172
20183
20192
20202
20216
20225
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Recruiting10
Terminated10
Unknown status8
Active, not recruiting3
No longer available1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals25
Gruppo Italiano Malattie EMatologiche dell'Adulto18
Bristol-Myers Squibb10
Pfizer5
University of Milano Bicocca3
Ariad Pharmaceuticals2
Carmen Fava2
Fred Hutchinson Cancer Center2
Teva Branded Pharmaceutical Products R&D, Inc.2
University of Bologna2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive93
Leukemia14
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Leukemia, Myeloid, Chronic-Phase11
Leukemia, Myeloid, Acute7
Myeloproliferative Disorders7
Philadelphia Chromosome7
Blast Crisis6
Bone Marrow Diseases6
Hodgkin Disease6

Trials

Showing 76 to 93 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.